Invacare reported $-6735000 in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Angiodynamics ANGO:US USD 2.76M 2.82M
Atricure ATRC:US USD -7736000 2.99M
Baxter International BAX:US USD 855M 68M
Boston Scientific BSX:US USD 860M 58M
Cardiovascular Systems CSII:US USD -9682000 1.4M
Cooper Companies COO:US USD 201.7M 20.6M
Cryolife CRY:US USD 2.28M 4.78M
Fisher Paykel Healthcare FPH:NZ NZD 169.5M 76.6M
Getinge GETIB:SS SEK 1.58B 228M
Globus Medical GMED:US USD 76.63M 6.97M
Insulet PODD:US USD 18.8M 1000K
Integra Lifesciences IART:US USD 105.31M 2.5M
Masimo MASI:US USD 79.2M 28.9M
Nuvasive NUVA:US USD 61.5M 436K
Philips PHIA:NA EUR 929M 299M
Resmed RMD:US USD 326.37M 13.62M
Smith & Nephew PLC SN/:LN 644M 21M
Steris STE:US USD 325.36M 12.56M
Stryker SYK:US USD 1.48B 389M
Tandem Diabetes Care TNDM:US USD -43985000 35.3M
Teleflex TFX:US USD 182.91M 8.88M
Terumo 4543:JP JPY 43.29B 3.74B